Courts banned this herbicide twice. The EPA wants to bring it back.

The EPA has proposed to re-register dicamba, a herbicide previously banned twice by federal courts due to significant off-target drift damage, citing new temperature-based application restrictions and drift reduction measures as mitigation. While agricultural industry players like Bayer and the American Soybean Association support the decision as crucial for managing resistant weeds, environmental groups and weed science experts strongly contest its efficacy, arguing the herbicide remains inherently problematic and vowing further legal challenges, raising concerns about industry influence at the EPA.

Analysis

The Environmental Protection Agency (EPA) has proposed the re-registration of dicamba-based herbicides, a move that re-ignites a significant conflict between agricultural stakeholders and environmental and scientific groups. This marks the third regulatory attempt for the herbicide, which was previously banned by federal courts in two separate instances due to findings of "substantial and undisputed damage" from off-target drift. The commercial stakes are high for manufacturers like Bayer, Syngenta, and BASF, as dicamba use nearly quadrupled to 31 million pounds annually between 2016 and 2019 to combat Roundup-resistant weeds. While the American Soybean Association and Bayer endorse the proposal, citing the product's value and the adequacy of new mitigation measures like temperature cutoffs, these measures are strongly contested. Scientific experts assert the chemical is "essentially impossible to contain," and environmental groups, who previously led successful lawsuits, argue the new rules actually loosen restrictions and have vowed to challenge the agency in court again. Compounding the issue are governance concerns, stemming from the recent appointment of a former industry lobbyist to a key EPA pesticide post, which critics claim signals undue industry influence and will likely feature in future litigation.

Key Decisions for Investors

• Investors in Bayer, BASF, and Syngenta should price in the high probability of renewed litigation, which has twice succeeded in vacating dicamba's registration and poses a direct risk to a significant revenue stream.
• The situation presents heightened headline risk and regulatory uncertainty; any final approval from the EPA will likely be immediately followed by legal challenges, creating continued volatility for the involved agrochemical stocks.
• The appointment of a former industry lobbyist to the EPA introduces a material governance and ESG risk factor that could attract scrutiny from sustainability-focused investors and impact the companies' reputations.
• Given the persistent legal and scientific challenges facing dicamba, investors should assess the competitive landscape for companies developing or marketing alternative, less controversial weed management solutions that could capture market share.